Last reviewed · How we verify

NCT04185792

Polish Translation and Validation of NBSS, Qualiveen and SF-Qualiveen

Completed Last updated 6 July 2022
What this trial tests

trial testing NBSS, Qualiveen and SF-Qualiveen in Spinal Cord Injuries in 200 participants. Completed in 18 September 2020.

Timeline
1 January 2020
Primary endpoint
18 September 2020
18 September 2020

Quick facts

Lead sponsorJagiellonian University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment200
Start date1 January 2020
Primary completion18 September 2020
Estimated completion18 September 2020
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Jagiellonian University

Who can join

18 and older, any sex, with Spinal Cord Injuries or Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to translate, culturally adapt, and validate Polish versions of the NBSS, Qualiveen and SF-Qualiveen questionnaires.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

Other Jagiellonian University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04185792.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing